Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Rockwell Medical stock

RMTI
US7743743004
916118

Price

2.31
Today +/-
+0.05
Today %
+2.48 %

Rockwell Medical stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Rockwell Medical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Rockwell Medical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Rockwell Medical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Rockwell Medical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Rockwell Medical Stock Price History

DateRockwell Medical Price
1/7/20252.31 undefined
1/6/20252.26 undefined
1/3/20252.33 undefined
1/2/20252.22 undefined
12/31/20242.04 undefined
12/30/20242.05 undefined
12/27/20242.14 undefined
12/26/20242.16 undefined
12/24/20242.15 undefined
12/23/20242.11 undefined
12/20/20242.08 undefined
12/19/20242.05 undefined
12/18/20242.09 undefined
12/17/20242.22 undefined
12/16/20242.01 undefined
12/13/20242.04 undefined
12/12/20242.07 undefined
12/11/20242.04 undefined
12/10/20242.08 undefined
12/9/20242.14 undefined

Rockwell Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Rockwell Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Rockwell Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Rockwell Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Rockwell Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Rockwell Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Rockwell Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Rockwell Medical’s growth potential.

Rockwell Medical Revenue, EBIT and net profit per share

DateRockwell Medical RevenueRockwell Medical EBITRockwell Medical Net Income
2027e151.16 M undefined12.24 M undefined0 undefined
2026e92.37 M undefined1.25 M undefined0 undefined
2025e84.85 M undefined-1.07 M undefined-1.81 M undefined
2024e102.49 M undefined1.97 M undefined824,160 undefined
202383.61 M undefined-6.67 M undefined-8.44 M undefined
202272.81 M undefined-16.78 M undefined-18.68 M undefined
202161.93 M undefined-30.34 M undefined-32.67 M undefined
202062.2 M undefined-28.42 M undefined-30.89 M undefined
201961.3 M undefined-34.1 M undefined-34.13 M undefined
201863.39 M undefined-31.41 M undefined-32.13 M undefined
201757.3 M undefined-25.92 M undefined-25.92 M undefined
201653.28 M undefined-20.21 M undefined-19.8 M undefined
201555.35 M undefined-15.1 M undefined-14.42 M undefined
201454.19 M undefined-17.56 M undefined-21.33 M undefined
201352.38 M undefined-47.06 M undefined-48.78 M undefined
201249.84 M undefined-54.26 M undefined-54.02 M undefined
201148.97 M undefined-21.68 M undefined-21.44 M undefined
201059.55 M undefined-2.87 M undefined-2.68 M undefined
200954.73 M undefined-5.48 M undefined-5.5 M undefined
200851.67 M undefined-8.09 M undefined-7.86 M undefined
200743.05 M undefined-3.61 M undefined-3.72 M undefined
200628.64 M undefined-4.64 M undefined-4.57 M undefined
200527.7 M undefined140,000 undefined80,000 undefined
200417.95 M undefined410,000 undefined210,000 undefined

Rockwell Medical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e
135679111417272843515459484952545553576361626172831028492151
-200.0066.6720.0016.6728.5722.2227.2721.4358.823.7053.5718.605.889.26-18.642.086.123.851.85-3.647.5510.53-3.171.64-1.6118.0315.2822.89-17.659.5264.13
800.00266.67160.00133.33114.2988.899.0914.2911.7611.117.144.653.9212.9615.2510.4212.2411.5414.8114.5511.325.26-1.593.283.23-3.285.569.647.849.528.705.30
0000001223222795668863-122-2480000
-1-1-1-1-1-10000-4-3-7-5-2-21-54-48-21-14-19-25-32-34-30-32-18-80-100
------------25.00133.33-28.57-60.00950.00157.14-11.11-56.25-33.3335.7131.5828.006.25-11.766.67-43.75-55.56----
2.90.270.430.440.440.540.720.840.850.851.021.071.261.341.561.621.852.993.764.554.614.644.85.546.878.539.8723.320000
--------------------------------
Details

Keystats

Revenue and Growth

The Rockwell Medical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Rockwell Medical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                       
0.070.091.931.090.360.380.010.120.180.32.6611.15.623.0424.217.534.7123.9285.7370.6857.9433.0633.5326.0458.6822.4421.4910.94
0.210.390.710.980.931.121.722.172.32.843.474.695.233.494.514.224.434.584.475.056.396.366.984.24.175.916.2610.9
000000000000000000000037000000
0.410.290.220.410.591.071.481.351.652.052.662.563.163.092.942.52.652.83.927.8712.147.644.043.653.914.085.815.87
0.050.10.030.030.10.110.120.10.110.190.260.30.440.331.021.641.360.620.591.032.031.781.92.982.712.861.751.06
0.740.872.892.511.982.683.333.744.245.389.0518.6514.4329.9532.6725.8913.1531.9294.7184.6378.548.8446.8236.8769.4735.2935.3128.77
0.730.70.930.70.821.721.731.942.052.432.592.843.253.633.052.291.861.651.51.651.392.552.645.655.5510.228.6111.02
0000000000000000000000000000
0000000000000000000000000000
000000.250.340.310.370.40.460.270.240.210.170.830.670.50.330.17000000010.76
01.441.281.121.090.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.920.92
00.430.180.140.170.510.140.130.120.140.130.130.120.160.1620.431.370.540.462.336.482.170.871.812.141.80.71
0.732.572.391.962.083.43.133.33.463.894.14.164.534.924.36.043.884.443.293.24.649.955.737.448.2813.2811.3323.4
1.473.445.284.474.066.086.467.047.79.2713.1522.8118.9634.8736.9731.9317.0336.369887.8383.1458.7952.5544.3177.7548.5746.6452.17
                                                       
03.638.658.769.0410.3511.7311.8311.8712.6323.1533.4234.853.5557.0267.4192.87154.46249.02257.77268.2273.21299.60.010.010.0100
0.0500.250.250.250.250.310.320.321.4203.043.387.648.287.17.184.900000326.78371.51372.55402.7418.49
-1.38-1.91-4.34-5.41-6.43-8-8.99-8.98-8.77-10.2-14.77-18.49-26.36-31.86-34.54-55.99-110.01-158.79-180.12-194.54-214.34-240.26-272.39-306.52-337.41-370.08-388.76-397.2
00000000000000-210-280030-200-920-900-4060506050160-1
0000000000000000000000000000
-1.331.724.563.62.862.63.053.173.423.858.3817.9711.8229.3330.5518.24-9.960.668.762.3152.9632.9127.2720.3234.172.5314.121.29
0.511.040.530.530.741.161.681.672.131.82.922.985.213.393.665.3614.838.695.2945.864.224.493.024.163.744.054.52
0.030.480.170.340.420.590.330.330.480.531.121.121.471.852.588.2312.026.654.333.834.214.725.136.016.187.099.718.53
1.8700000000.010.030.050.340.250.250.170.10.140.210.180.260.080.213.582.582.462.321.82.79
000000.550.420.640.451.800000000000000.7600.440.50.24
0.380.2000.010.280.20.310.390.520.370.190.180.040.020.0102.3100000007.381.630.56
2.791.720.70.871.172.582.632.953.464.684.464.637.115.536.4313.726.9917.869.88.0910.159.1513.212.3712.820.9717.6916.64
00000.020.890.780.930.820.730.330.20.040.020.0100000000020.9513.197.569.82
0000000000000000000000000000
0000000000000000017.9219.4917.4120.0516.7212.0811.629.8411.897.284.42
00000.020.890.780.930.820.730.330.20.040.020.010017.9219.4917.4120.0516.7212.0811.6230.7925.0814.8414.25
2.791.720.70.871.193.473.413.884.285.414.794.837.155.556.4413.726.9935.7829.2925.530.225.8725.2823.9943.5946.0532.5330.88
1.463.445.264.474.056.076.467.057.79.2613.1722.818.9734.8836.9931.9417.0336.3897.9987.8183.1658.7852.5544.3177.7648.5846.6352.17
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Rockwell Medical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Rockwell Medical's financial health and stability.

Assets

Rockwell Medical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Rockwell Medical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Rockwell Medical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Rockwell Medical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (k)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
-1-1-1-1-1-10000-4-3-7-5-2-21-54-48-21-14-19-25-32-34-30-32-18
00000000000001,0001,0001,0001,0001,0001,00000000000
000000000000000000000000000
000000000-100100414-1112-8-3-3-3-1-2-4-2
000000000000124478118107148333
000000000000000001300000111
000000000000000000000000000
-1-1-2000-1010-3-3-4-12-10-30-504-13-12-21-20-27-29-33-17
00000-10000-10-1-10000000-100-100
00000-10000-10-1-1-12011-12-8-21-11412-430-2
00000000000000-12012-12-8-20-11613-440-2
000000000000000000000000000
0000010000-200000020-210000-121-2-13
024001100091302004185179200222445030
11400200016120200418705800-2222163-216
1,0000000000000000000-1,0000-2,0000-2,0000-2,000-3,00000
000000000000000000000000000
001000000028-517-10-6-1753-34-14-814-1036-35-3
-1.82-1.32-2.78-0.88-0.81-2.22-1.570.060.55-1.13-4.42-4.33-5.54-3.031.33-11.35-31.26-51.313.58-14.15-12.81-22.79-21.16-27.84-30.69-34.05-17.69
000000000000000000000000000

Rockwell Medical stock margins

The Rockwell Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Rockwell Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Rockwell Medical.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Rockwell Medical's sales revenue. A higher gross margin percentage indicates that the Rockwell Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Rockwell Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Rockwell Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Rockwell Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Rockwell Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Rockwell Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Rockwell Medical Margin History

Rockwell Medical Gross marginRockwell Medical Profit marginRockwell Medical EBIT marginRockwell Medical Profit margin
2027e10.41 %8.1 %0 %
2026e10.41 %1.36 %0 %
2025e10.41 %-1.26 %-2.14 %
2024e10.41 %1.92 %0.8 %
202310.41 %-7.98 %-10.09 %
20225.6 %-23.05 %-25.66 %
2021-3.91 %-48.99 %-52.75 %
20204.39 %-45.69 %-49.66 %
20194.63 %-55.63 %-55.68 %
2018-2.49 %-49.55 %-50.69 %
20176.46 %-45.24 %-45.24 %
201612.67 %-37.93 %-37.16 %
201516.15 %-27.28 %-26.05 %
201415.78 %-32.4 %-39.36 %
201312.71 %-89.84 %-93.13 %
201213.42 %-108.87 %-108.39 %
201111.52 %-44.27 %-43.78 %
201016.56 %-4.82 %-4.5 %
200914.42 %-10.01 %-10.05 %
20084.86 %-15.66 %-15.21 %
20076.71 %-8.39 %-8.64 %
20069.78 %-16.2 %-15.96 %
200510.87 %0.51 %0.29 %
200415.65 %2.28 %1.17 %

Rockwell Medical Stock Sales Revenue, EBIT, Earnings per Share

The Rockwell Medical earnings per share therefore indicates how much revenue Rockwell Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Rockwell Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Rockwell Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Rockwell Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Rockwell Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Rockwell Medical Revenue, EBIT and net profit per share

DateRockwell Medical Sales per ShareRockwell Medical EBIT per shareRockwell Medical Earnings per Share
2027e4.68 undefined0 undefined0 undefined
2026e2.86 undefined0 undefined0 undefined
2025e2.63 undefined0 undefined-0.06 undefined
2024e3.17 undefined0 undefined0.03 undefined
20233.58 undefined-0.29 undefined-0.36 undefined
20227.38 undefined-1.7 undefined-1.89 undefined
20217.26 undefined-3.56 undefined-3.83 undefined
20209.05 undefined-4.14 undefined-4.5 undefined
201911.06 undefined-6.16 undefined-6.16 undefined
201813.21 undefined-6.54 undefined-6.69 undefined
201712.35 undefined-5.59 undefined-5.59 undefined
201611.56 undefined-4.38 undefined-4.3 undefined
201512.16 undefined-3.32 undefined-3.17 undefined
201414.41 undefined-4.67 undefined-5.67 undefined
201317.52 undefined-15.74 undefined-16.31 undefined
201226.94 undefined-29.33 undefined-29.2 undefined
201130.23 undefined-13.38 undefined-13.23 undefined
201038.17 undefined-1.84 undefined-1.72 undefined
200940.84 undefined-4.09 undefined-4.1 undefined
200841.01 undefined-6.42 undefined-6.24 undefined
200740.23 undefined-3.37 undefined-3.48 undefined
200628.08 undefined-4.55 undefined-4.48 undefined
200532.59 undefined0.16 undefined0.09 undefined
200421.12 undefined0.48 undefined0.25 undefined

Rockwell Medical business model

Rockwell Medical is one of the most popular companies on Eulerpool.com.

Rockwell Medical Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Rockwell Medical Revenue by Segment

Segmente20192018
Concentrate Products54.52 M USD8.73 M USD
Product59 M USD-
Concentrate Product Sales6.24 M USD-
License2.3 M USD-
Concentrate Product License Fee1.98 M USD-
Drug Revenues273,000 USD-
Drug Revenue-273,000 USD
Drug Product Sales--
Drug License Fee--

Rockwell Medical Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Rockwell Medical Revenue by Segment

DateNon UsRest of WorldU [S]U.S
2019-6.51 M USD-54.52 M USD
20188.73 M USD-52.26 M USD-
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Rockwell Medical Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Rockwell Medical historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Rockwell Medical shares outstanding

The number of shares was Rockwell Medical in 2024 — This indicates how many shares 23.323 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Rockwell Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Rockwell Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Rockwell Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Rockwell Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Rockwell Medical stock splits

In Rockwell Medical's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Rockwell Medical.

Rockwell Medical latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.01 0.05  (390.2 %)2024 Q3
6/30/2024-0.04 0.01  (125.21 %)2024 Q2
3/31/2024-0.04 -0.06  (-47.06 %)2024 Q1
12/31/2023-0.07 -0.05  (29.97 %)2023 Q4
9/30/2023-0.11 -0.07  (34.64 %)2023 Q3
6/30/2023-0.12 -0.18  (-47.06 %)2023 Q2
3/31/2023-0.17 -0.1  (40.58 %)2023 Q1
12/31/2022-0.4 -0.2  (49.72 %)2022 Q4
9/30/2022-0.49 -0.4  (19.14 %)2022 Q3
6/30/2022-0.83 -0.56  (32.22 %)2022 Q2
1
2
3
4
5
...
7

Eulerpool ESG Scorecard© for the Rockwell Medical stock

Eulerpool World ESG Rating (EESG©)

21/ 100

🌱 Environment

5

👫 Social

33

🏛️ Governance

26

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Rockwell Medical shareholders

%
Name
Stocks
Change
Date
9.96795 % Armistice Capital LLC3,221,640592,0006/30/2024
9.46009 % Irrevocable Larson Family Investment Trust3,057,500150,00010/3/2024
3.46002 % The Vanguard Group, Inc.1,118,27706/30/2024
1.08419 % Perkins Capital Management, Inc.350,4091,7256/30/2024
0.94477 % Geode Capital Management, L.L.C.305,34916,5896/30/2024
0.85652 % Richmond Brothers, Inc.276,828-45,4236/30/2024
0.65799 % BlackRock Institutional Trust Company, N.A.212,66237,4996/30/2024
0.56113 % GSA Capital Partners LLP181,356181,3566/30/2024
0.40576 % Ravich (Mark H)131,14336,1115/21/2024
0.32125 % Citadel Advisors LLC103,82846,8286/30/2024
1
2
3
4
5
...
10

Rockwell Medical Executives and Management Board

Dr. Mark Strobeck

(52)
Rockwell Medical President, Chief Executive Officer, Director (since 2022)
Compensation 711,772

Ms. Megan Timmins

(50)
Rockwell Medical Executive Vice President, Chief Legal Officer, Secretary
Compensation 607,291

Dr. Marc Hoffman

(62)
Rockwell Medical Chief Medical Officer
Compensation 586,612

Mr. Robert Radie

(59)
Rockwell Medical Independent Chairman of the Board
Compensation 132,000

Mr. John Cooper

(64)
Rockwell Medical Independent Director
Compensation 121,500
1
2
3

Rockwell Medical Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,920,920,840,590,65-0,47
ELGI Equipments Stock
ELGI Equipments
SupplierCustomer0,66-0,74-0,27-0,38-0,73-0,83
SupplierCustomer-0,07-0,370,250,400,910,42
Shanghai Fosun Pharm H Stock
Shanghai Fosun Pharm H
SupplierCustomer-0,12-0,290,320,330,83-0,15
SupplierCustomer-0,17-0,550,420,500,050,25
Sun Pharmaceutical Inds Stock
Sun Pharmaceutical Inds
SupplierCustomer-0,89-0,040,23-0,26-0,82-0,85
1

Most common questions regarding Rockwell Medical

What is the P/E ratio of Rockwell Medical 2025?

The Rockwell Medical P/E ratio is -29.74.

What is the P/S ratio of Rockwell Medical 2025?

The Rockwell Medical P/S ratio is 0.64.

What is the Quality Investing of Rockwell Medical?

The Quality Investing for Rockwell Medical is 3/10.

What is the revenue of Rockwell Medical 2025?

The expected Rockwell Medical revenue is 84.85 M USD.

How high is the profit of Rockwell Medical 2025?

The expected Rockwell Medical profit is -1.81 M USD.

What is the business model of Rockwell Medical

No history available for Rockwell Medical.

What is the Rockwell Medical dividend?

Rockwell Medical pays a dividend of 0 USD distributed over payouts per year.

How often does Rockwell Medical pay dividends?

The dividend cannot currently be calculated for Rockwell Medical or the company does not pay out a dividend.

What is the Rockwell Medical ISIN?

The ISIN of Rockwell Medical is US7743743004.

What is the Rockwell Medical WKN?

The WKN of Rockwell Medical is 916118.

What is the Rockwell Medical ticker?

The ticker of Rockwell Medical is RMTI.

How much dividend does Rockwell Medical pay?

Over the past 12 months, Rockwell Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Rockwell Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Rockwell Medical?

The current dividend yield of Rockwell Medical is .

When does Rockwell Medical pay dividends?

Rockwell Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Rockwell Medical?

Rockwell Medical paid dividends every year for the past 0 years.

What is the dividend of Rockwell Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Rockwell Medical located?

Rockwell Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Rockwell Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rockwell Medical from 1/7/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/7/2025.

When did Rockwell Medical pay the last dividend?

The last dividend was paid out on 1/7/2025.

What was the dividend of Rockwell Medical in the year 2024?

In the year 2024, Rockwell Medical distributed 0 USD as dividends.

In which currency does Rockwell Medical pay out the dividend?

The dividends of Rockwell Medical are distributed in USD.

All fundamentals about Rockwell Medical

Our stock analysis for Rockwell Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rockwell Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.